Corporate Overview
Advancing the Future of Healthcare
At YD Biopharma, we are committed to advancing healthcare through biotechnology and precision medicine. Since our establishment, we have focused on developing innovative approaches aimed at addressing significant unmet medical needs worldwide.
Advancing Innovation for a Healthier Future
Our mission is clear and impactful: advancing innovative biotechnology solutions to improve healthcare and patient outcomes worldwide. By leveraging advanced technologies, we aim to enhance diagnostic precision, support the development of effective therapeutic approaches, and contribute to meaningful improvements in patient care. We envision a future where scientific innovation bridges diagnostics and treatment, empowering individuals to live healthier and longer lives.
Advancing Healthcare Through Innovation
We envision a future where scientific innovation bridges diagnostics and treatment, enabling individuals to achieve better health and improved quality of life.
Innovation
Advancing next-generation biopharmaceutical solutions through continuous research and technological development.
Patient-Centered
Dedicated to improving patient outcomes through advancements in regenerative medicine and immunotherapy.
Collaboration
Partnering with leaders across the biotechnology and pharmaceutical sectors to drive meaningful global progress.
Excellence
Committed to the highest standards of scientific rigor, manufacturing quality, and regulatory compliance.
Integrity
Upholding transparency, ethical principles, and trust in all partnerships and operations.
Our Values
2013
YD Biopharma was established with a focus on pharmaceutical operations and clinical trial support services.
2015
Established partnerships with global pharmaceutical leaders, including Novartis, to support the supply of clinical trial investigational drugs.
2022
Initiated collaboration with 3D GLOBAL BIOTECH INC. to advance the development of exosome-based therapies for ophthalmic applications.
2024
Expanded into cancer detection technologies through collaboration with EG Biomed, leading to the establishment of an independent laboratory in the United States.
Our Journey